Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. The firm's strategy centers on advancing innovative treatments for severe diseases to impact patients’ lives. They focus on backing great teams with development programs that can make a true difference for patients.
Preferred startup development maturity for initial funding deployment.
Drug development, Biological drugs, Novel therapeutics, Oncology, Fibrotic diseases, Neurological diseases, Respiratory diseases, Inflammatory diseases, Heart failure, Kidney injury
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...